Bibi Kulsoom

Associate Professor

Education

  • MBBS from Liaquat University of Medical & Health Sciences (LUMS), Hyderabad & Jamshoro.
  • MPhil from Ziauddin University, Karachi.
  •  PhD from Ziauddin University, Karachi.

Experience

  • Associate Professor BiochemistryJinnah Medical & Dental College,
    Karachi, Pakistan,2018 Oct –to date
  • Lecturer of Biochemistry, Alfaisal University, Riyadh, Saudi Arabia.2010 Oct–2018Aug
  • Assistant Professor of Biochemistry (4 Years and 6 months).Ziauddin University, Karachi, Pakistan,2006 Mar–2010 Sep
  • Lecturer of Biochemistry and M.Phil candidate.Ziauddin University, Karachi, Pakistan.2001 Feb–2006 Mar
  • Demonstrator of Biochemistry,ISRA UNIVERSITY, Hyderabad, Pakistan 1999 Sep–Oct 2000
  • House Officer Medicine, Paediatrics and Obstetrics & Gynaecology Liaquat Medical College Hospital Hyderabad/ Jamshoro, Pakistan 1998 Sep–1999 Aug

Research Focus

  • Cancer Biology, Genetics, metabolism, Biochemistry, Psychological disorders, Medical education.
  • I am specifically interested in genomics and proteomics of AML as well as chemotherapy resistance, molecular mechanisms underlying different diseases such as AML and other cancers as well as cardiovascular diseases and metabolic disorders.
  • I am interested in studying inflammatory markers such as C-reactive protein. I am also interested in medical education, student psychology and the outcome of different teaching methodologies.

Keywords

  • Acute Myeloid Leukemia, dCMPD, LRP, MRP, MDR

Publications

  • 2019; Kulsoom B, Shamsi TS, Afsar NA. Lung resistance-related protein (LRP) predicts favorable therapeutic outcome in Acute Myeloid Leukemia. Sci Rep. 2019 Jan 23; 9(1):378. doi: 10.1038/s41598-018-36780-8.
  • 2018; Kulsoom B, Shamsi TS, Afsar NA. Gene expression of hENT1, dCK, CDA, dCMPD and topoisomerase IIα as an indicator of chemotherapy response in AML treated with cytarabine and daunorubicin. Cancer Manag Res. 2018 Nov 9;10: 5573-5589.
  • 2018; Bax, Bcl-2 and Bax/Bcl-2 as Prognostic Markers in Acute Myeloid Leukemia. Are we ready for Bcl-2 directed therapy? Cancer Manag Res 10:403-16.
  • 2017; Kulsoom B, Shamsi TS, Ahmed N, Hasnain SN. Clinical Presentation of Acute Myeloid Leukemia – A Decade-long Institutional Follow-up. J Pak Med Assoc 67:1837-42.
  • 2017; Kulsoom B, Shamsi TS, Ahmed N, Hasnain SN. Recent advances in diagnostic and prognostic aspects of acute myeloid leukemia. J Pak Med Assoc. 2017; 67:1580-7.
  • 2015; Kulsoom B, Afsar NA. Stress, anxiety, and depression among medical students in a multiethnic setting. Neuropsychiatr Dis Treat 11:1713-22.
  • 2010; Afsar NA, Kulsoom B, Mateen A, Ahmed S, Tahseen M, Ahmed A. Breast Cancer Pattern and Chemotherapy Response – an Institutional Study in Pakistan. Asian Pac J Cancer Prev, 11:825-30.
  • 2006; Kulsoom B, Hasnain SN. Association of serum C-reactive protein and LDL:HDL with myocardial infarction. J Pak Med Assoc. 2006;56(7):318-22.
  • 2006; Kulsoom B, Hasnain SN. C-reactive protein and Statins. Pakistan Journal of Pharmacology. 2006;23(2):49-54.